Programme Content
Evaluate financing options specific to the life sciences industry, including the pharmaceutical, biotechnology, and medtech sectors
Make financing decisions in the context of drug development phase, cash runway requirements, repayment obligations, potential need for future financing rounds, product risk profile, and other factors
Structure venture capital rounds and prepare for IPOs while balancing dilution concerns with capital needs
Assess the benefits of royalty monetization transactions for pipeline assets
Balance upfront capital needs with long-term value retention
Negotiate strategic partnerships and licensing agreements that provide non-dilutive capital while maintaining flexibility
Leverage off-balance sheet financing
